Explore how chemotherapy causes peripheral neuropathy in 40% of cancer patients. Learn about the risk factors and the need ...

Leerink Partners analyst Roanna Ruiz has maintained their bullish stance on LXRX stock, giving a Buy rating yesterday.Invest with Confidence: ...

The growing geriatric population will further boost the adoption of pain monitoring devices and will lead to an increase in ...

Pain management is a critical area of healthcare ... One innovative approach that has gained traction in recent years is Peripheral Nerve Stimulation (PNS). This technique involves the ...

The Company anticipates completing enrollment of the 48-patient trial by the end of 2Q 2025 and releasing top-line data on the Phase 2a trial in 4Q 2025. Results from this trial are anticipated to be ...

VMPL Pune Maharashtra [India] January 24 Living with chronic spine and back pain can be tough making everyday tasks difficult ...

Objective: To assess the efficacy, safety and impact on quality of life of tramadol in the treatment of neuropathic pain in patients with cancer. Methods: Patients with similar characteristics ...

Chronic pain is a global health challenge, with current treatment options often limited by side effects, addiction risk, and diminished effectiveness over time. In a new study, Yale researchers ...

Our goal is to relieve pain and help patients regain function without surgery. We create personalized care plans to address each ...

“When you talk about a pinched nerve in the neck, that’s usually going to bring on symptoms in the neck and sometimes the ...

SPR announces four featured abstracts that will be presented at the upcoming North American Neuromodulation Society (NANS) Annual Meeting in Orlando 29 – February 1. All the abstracts contain recent ...

Pain is one of the most debilitating symptoms that presents with neuropathy. Neuropathic pain syndrome is a challenge to treat and, even with appropriate evidence-based treatment, only a 40% ...